2020 ASCO Virtual Direct™ Highlights

 

2020 ASCO Virtual Direct™ Highlights
D

2020 ASCO Update on Waldenström Macroglobulinemia: Zanubrutinib vs. Ibrutinib - Which BTKi Option is Better?

By 2020 ASCO Virtual Direct™ Highlights FEATURING David Maloney
By 2020 ASCO Virtual Direct™ Highlights FEATURING David Maloney
339 views
August 18, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

11:42
ImmunoGen

Best Practices for the management of ocular adverse events associate…

Feat. K. Lamoreau

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison
Hematologic Oncology
09:23

2020 ASCO Update on Hodgkin Lymphoma: Pembro vs. Brentuximab Vedotin…

2020 ASCO Virtual Direct™ Highlights

D. Maloney

150 views
08:34

2020 ASCO Update on Waldenström Macroglobulinemia: Zanubrutinib vs. …

2020 ASCO Virtual Direct™ Highlights

D. Maloney

339 views
07:09

2020 ASCO Update on DLBCL: Venetoclax + Dose-Adjusted R-EPOCH - Did …

2020 ASCO Virtual Direct™ Highlights

D. Maloney

186 views
10:30

2020 ASCO Update on FL: Is CAR-T Axi-Cel Therapy a Promising Therape…

2020 ASCO Virtual Direct™ Highlights

D. Maloney

101 views